ISIS: ISIS PHARMACEUTICALS INC Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 16 hrs, 33 mins

Symbol	Value	Change	Percentage Change
DJIA	10,226.94	203.52	2.03%
NASDAQ	2,154.06	41.62	1.97%
S&P 500	1,093.07	23.77	2.22%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

ISIS PHARMACEUTICALS INC

ISIS

Stock price

13.58 0.12 0.89%

as of 04:00 PM EST on 11/09/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

13.5563 -0.0237 -0.17%

as of 04:12 PM EST on 11/09/09

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ISIS

ISIS PHARMACEUTICALS INC Real-Time Headlines

Customize
Friday, November 6, 2009

Isis Pharmaceuticals Inc. Reports Operating Results (10-Q)

11/6/09 | GuruFocus

SEC Filing: Quarterly Financials

11/6/09 View all Related Articles > | Thomson Financial

Thursday, November 5, 2009

Isis Pharma Swings To Loss In Q3 - Update

11/5/09 | RTTNews

Isis Pharma projecting to end 2009 in the strongest financial position

11/5/09 | Theflyonthewall.com

Isis Pharmaceuticals reports Q3 EPS (7c) vs. consensus of (7c)

11/5/09 | Theflyonthewall.com

Thursday, October 29, 2009

Excaliard, an Isis Pharmaceuticals, Inc. Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials

10/29/09 View all Related Articles > | Pharm Country

Wednesday, October 28, 2009

Webcast Alert: Isis Pharmaceuticals' Third Quarter 2009 Financial Results Conference Calls

10/28/09 View all Related Articles > | PharmaLive

Regulus Therapeutics receives US allowance of microRNA Therapeutics patent

10/28/09 | Theflyonthewall.com

Regulus Announces U.S. Allowance of Fundamental microRNA Therapeutics Patent Application

10/28/09 | Business Wire

Tuesday, October 27, 2009

Webcast Alert: Isis Pharmaceuticals' Third Quarter 2009 Financial Results Conference Calls

10/27/09 | PR Newswire

Friday, October 23, 2009

Isis Diabetes Drug Shows Promise - Analyst Blog

10/23/09 | Zacks Investment Research

Thursday, October 22, 2009

Isis Pharmaceuticals, Inc. Diabetes Drug Shows Promise in Mid-Stage

10/22/09 View all Related Articles > | Pharm Country

Isis Pharmaceuticals positive data an unexpected surprise, says Collins Stewart

10/22/09 | Theflyonthewall.com

Isis Pharmaceuticals weakness a buying opportunity, says Piper Jaffray

10/22/09 | Theflyonthewall.com

Isis Pharmaceuticals trial results positive, says Cantor

10/22/09 | Theflyonthewall.com

Wednesday, October 21, 2009

SEC Filing: Current Event

10/21/09 | Thomson Financial

Isis Pharmaceuticals to host conference call

10/21/09 | Theflyonthewall.com

Isis Pharmaceuticals reports positive phase 2 data for ISIS 113715

10/21/09 | Theflyonthewall.com

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 113715 in Patients With Type 2 Diabetes

10/21/09 | PR Newswire

Tuesday, October 20, 2009

Isis Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference

10/20/09 | PR Newswire

Tuesday, October 6, 2009

5 Stocks Approaching Greatness

10/6/09 | The Motley Fool

Friday, October 2, 2009

SEC Filing: Current Event

10/2/09 | Thomson Financial

Thursday, October 1, 2009

Isis Pharmaceuticals management to meet with Needham

10/1/09 | Theflyonthewall.com

Tuesday, September 29, 2009

Isis Pharmaceuticals to Present at the 4th Annual JMP Securities Healthcare Focus Conference

9/29/09 View all Related Articles > | PharmaLive

Isis Pharmaceuticals to Present at the 4th Annual JMP Securities Healthcare Focus Conference

9/29/09 | PR Newswire

Thursday, September 17, 2009

Regulus, Alnylam, and Isis Announce First microRNA Patent Grant in Japan from Tuschl III Patent Series

9/17/09 | Business Wire

Wednesday, September 16, 2009

Regulus Therapeutics Appoints Hubert C. Chen, M.D., Vice President of Translational Medicine

9/16/09 | Business Wire

Tuesday, September 15, 2009

4-Star Stocks on the Upswing

9/15/09 | The Motley Fool

Thursday, September 10, 2009

Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology

9/10/09 | PR Newswire

Wednesday, September 9, 2009

Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged Conference

9/9/09 | PR Newswire

Tuesday, September 8, 2009

Sector Snap: Analyst keeps positive biotech view

9/8/09 | AP ONLINE

Thursday, September 3, 2009

Isis Pharmaceuticals to Present at Thomas Weisel Partners' Healthcare Conference 2009

9/3/09 | PR Newswire

Wednesday, September 2, 2009

SEC Filing: 40-APP Notice

9/2/09 | Thomson Financial

Monday, August 17, 2009

SEC Filing: Insider Buy/Sell

8/17/09 | Thomson Financial

Friday, August 14, 2009

Beacon Equity Issues Trading Outlook for Isis Pharmaceuticals

8/14/09 View all Related Articles > | TradingMarkets

Beacon Equity Issues Trading Outlook for Isis Pharmaceuticals

8/14/09 | GlobeNewswire

Tuesday, August 11, 2009

ISIS Pharmaceuticals (NasdaqGM: ISIS) Makes Antisense

8/11/09 View all Related Articles > | iStockAnalyst

Alnylam and Regulus Receive Notice of Allowance from United States Patent and Trademark Office for New Patent Covering microRNA Therapeutics

8/11/09 | Business Wire

Thursday, August 6, 2009

Isis Pharmaceuticals Inc. Reports Operating Results (10-Q)

8/6/09 | GuruFocus

SEC Filing: Quarterly Financials

8/6/09 View all Related Articles > | Thomson Financial

1 <Next>
Friday, November 6, 2009

Isis Pharmaceuticals Inc. Reports Operating Results (10-Q)

11/6/09 | GuruFocus

SEC Filing: Quarterly Financials

11/6/09 View all News Related Articles > | Thomson Financial

Thursday, November 5, 2009

Isis Pharma Swings To Loss In Q3 - Update

11/5/09 | RTTNews

Isis Pharma projecting to end 2009 in the strongest financial position

11/5/09 | Theflyonthewall.com

Isis Pharmaceuticals reports Q3 EPS (7c) vs. consensus of (7c)

11/5/09 | Theflyonthewall.com

Wednesday, October 28, 2009

Regulus Therapeutics receives US allowance of microRNA Therapeutics patent

10/28/09 | Theflyonthewall.com

Friday, October 23, 2009

Isis Diabetes Drug Shows Promise - Analyst Blog

10/23/09 | Zacks Investment Research

Thursday, October 22, 2009

Isis Pharmaceuticals positive data an unexpected surprise, says Collins Stewart

10/22/09 | Theflyonthewall.com

Isis Pharmaceuticals weakness a buying opportunity, says Piper Jaffray

10/22/09 | Theflyonthewall.com

Isis Pharmaceuticals trial results positive, says Cantor

10/22/09 | Theflyonthewall.com

Wednesday, October 21, 2009

SEC Filing: Current Event

10/21/09 | Thomson Financial

Isis Pharmaceuticals to host conference call

10/21/09 | Theflyonthewall.com

Isis Pharmaceuticals reports positive phase 2 data for ISIS 113715

10/21/09 | Theflyonthewall.com

Isis CEO says cholesterol drug will be "remarkable" advance, Xconomy reports

10/21/09 | Theflyonthewall.com

Tuesday, October 6, 2009

5 Stocks Approaching Greatness

10/6/09 | The Motley Fool

Friday, October 2, 2009

SEC Filing: Current Event

10/2/09 | Thomson Financial

Thursday, October 1, 2009

Isis Pharmaceuticals management to meet with Needham

10/1/09 | Theflyonthewall.com

Tuesday, September 15, 2009

4-Star Stocks on the Upswing

9/15/09 | The Motley Fool

Tuesday, September 8, 2009

Sector Snap: Analyst keeps positive biotech view

9/8/09 | AP ONLINE

Wednesday, September 2, 2009

SEC Filing: 40-APP Notice

9/2/09 | Thomson Financial

Monday, August 17, 2009

SEC Filing: Insider Buy/Sell

8/17/09 | Thomson Financial

Friday, August 14, 2009

Beacon Equity Issues Trading Outlook for Isis Pharmaceuticals

8/14/09 | TradingMarkets

Thursday, August 6, 2009

Isis Pharmaceuticals Inc. Reports Operating Results (10-Q)

8/6/09 | GuruFocus

SEC Filing: Quarterly Financials

8/6/09 View all News Related Articles > | Thomson Financial

Isis Pharma Q2 Loss Narrows - Update

8/6/09 | RTTNews

Stock sale helps Isis Pharma to smaller 2Q loss

8/6/09 | AP ONLINE

Friday, July 24, 2009

SEC Filing: Insider Buy/Sell

7/24/09 | Thomson Financial

Tuesday, July 21, 2009

4-Star Stocks on the Upswing

7/21/09 | The Motley Fool

Thursday, July 16, 2009

Top-Rated Stocks That Treat Shareholders Right

7/16/09 | The Motley Fool

Wednesday, July 8, 2009

SEC Filing: Insider Buy/Sell

7/8/09 View all News Related Articles > | Thomson Financial

Thursday, July 2, 2009

SEC Filing: Insider Buy/Sell

7/2/09 View all News Related Articles > | Thomson Financial

Tuesday, June 30, 2009

5 Stocks Approaching Greatness

6/30/09 | The Motley Fool

Friday, June 26, 2009

SEC Filing: Employee benefit Plans

6/26/09 View all News Related Articles > | Thomson Financial

Wednesday, June 24, 2009

Zacks Analyst Blog Highlights: Tiffany, Big Lots, Family Dollar, Isis Pharmaceuticals and OncoGenex

6/24/09 View all News Related Articles > | TradingMarkets

Tuesday, June 23, 2009

Isis Generating Impressive Data - Analyst Blog

6/23/09 | Zacks Investment Research

Dream Stocks for Biotech Investors

6/23/09 | The Motley Fool

Wednesday, June 17, 2009

SEC Filing: Current Event

6/17/09 | Thomson Financial

Thursday, June 11, 2009

Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference

6/11/09 | The Pink Sheet Daily

Tuesday, June 9, 2009

PicksThatMove: Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) We have picks that move!

6/9/09 View all News Related Articles > | TradingMarkets

Friday, June 5, 2009

Isis Pharmaceuticals to Present at Needham's 8th Annual Life Sciences Conference

6/5/09 | The Pink Sheet Daily

1 <Next>
Thursday, October 29, 2009

Excaliard, an Isis Pharmaceuticals, Inc. Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials

10/29/09 View all Trade Related Articles > | Pharm Country

Wednesday, October 28, 2009

Webcast Alert: Isis Pharmaceuticals' Third Quarter 2009 Financial Results Conference Calls

10/28/09 View all Trade Related Articles > | PharmaLive

Thursday, October 22, 2009

Isis Pharmaceuticals, Inc. Diabetes Drug Shows Promise in Mid-Stage

10/22/09 View all Trade Related Articles > | Pharm Country

Tuesday, September 29, 2009

Isis Pharmaceuticals to Present at the 4th Annual JMP Securities Healthcare Focus Conference

9/29/09 | PharmaLive

Tuesday, August 11, 2009

ISIS Pharmaceuticals (NasdaqGM: ISIS) Makes Antisense

8/11/09 | iStockAnalyst

Wednesday, June 24, 2009

Zacks Analyst Blog Highlights: Tiffany, Big Lots, Family Dollar, Isis Pharmaceuticals and OncoGenex

6/24/09 View all Trade Related Articles > | PR-inside - Austria

Thursday, June 11, 2009

Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference

6/11/09 View all Trade Related Articles > | PharmaLive

Friday, June 5, 2009

Isis Pharmaceuticals to Present at Needham's 8th Annual Life Sciences Conference

6/5/09 View all Trade Related Articles > | PharmaLive

Thursday, June 4, 2009

Isis Pharmaceuticals to Present at Goldman Sachs' 30th Annual Global Healthcare Conference

6/4/09 | The Pink Sheet Daily

Monday, June 1, 2009

Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders

6/1/09 | The Pink Sheet Daily

Wednesday, May 20, 2009

Genzyme Corporation, Isis Pharmaceuticals, Inc. Cholesterol Drug Meets Study Goal

5/20/09 View all Trade Related Articles > | Pharm Country

Tuesday, May 19, 2009

Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders

5/19/09 View all Trade Related Articles > | PharmaLive

Thursday, May 7, 2009

Isis Pharmaceuticals, Inc. Posts Q1 Profit on One-time Gain

5/7/09 View all Trade Related Articles > | Pharm Country

Isis Reports Strong Financial Results and Highlights for First Quarter of 2009

5/7/09 View all Trade Related Articles > | The Pink Sheet Daily

Wednesday, April 29, 2009

Isis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals Form New Collaboration to Develop Single-Stranded RNAi Technology; Will Pay Up to $31 Million

4/29/09 View all Trade Related Articles > | Pharm Country

Friday, April 24, 2009

Webcast Alert: Isis Pharmaceuticals' First Quarter 2009 Financial Results Conference Call

4/24/09 | PharmaLive

Thursday, April 23, 2009

Webcast Alert: Isis Pharmaceuticals' First Quarter 2009 Financial Results Conference Call

4/23/09 | StockWatch

Tuesday, April 7, 2009

Zacks Analyst Blog Highlights: Isis Pharmaceuticals, Cosan Ltd., Petrobras, Bristol-Myers Squibb Co. and HSBC Holdings

4/7/09 | PR-inside - Austria

Wednesday, March 25, 2009

Isis Pharmaceuticals to Present at the 4th Annual Citi Biotech Day

3/25/09 View all Trade Related Articles > | PharmaLive

Thursday, February 19, 2009

Webcast Alert: Isis Pharmaceuticals Announces Its 2008 Financial Results and Highlights Conference Call

2/19/09 | PharmaLive

Friday, January 9, 2009

Zacks Bull & Bear of the Day Highlights: Isis Pharmaceuticals, LeapFrog, Johnson & Johnson, Exxon

1/9/09 | PR-inside - Austria

Thursday, January 8, 2009

Isis Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference

1/8/09 View all Trade Related Articles > | The Pink Sheet Daily

Wednesday, December 31, 2008

Massachusetts Life Sciences Center, Immune Disease Institute, Baxter Healthcare, Epic Therapeutics, RXi Pharmaceuticals, University of Massachusetts Medical School, Alnylam Pharmaceuticals, Tekmira Pharmaceuticals, Isis Pharmaceuticals, Abbott, Ibis Biosc

12/31/08 | GenomeWeb

Wednesday, December 24, 2008

Abbott and Isis Announce Hart-Scott-Rodino Clearance of Abbott's Acquisition of Ibis Biosciences, a Subsidiary of Isis

12/24/08 View all Trade Related Articles > | Biocompare

Wednesday, December 17, 2008

Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences

12/17/08 View all Trade Related Articles > | PharmaLive

Friday, December 5, 2008

Isis Pharmaceuticals, Inc. - SWOT Analysis - http://www.companiesandmarkets.com adds new report

12/5/08 | PR-inside - Austria

Wednesday, December 3, 2008

Isis Pharmaceuticals, Inc. (ISIS) Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study

12/3/08 View all Trade Related Articles > | Biocompare

Monday, December 1, 2008

Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call

12/1/08 View all Trade Related Articles > | PharmaLive

Monday, November 10, 2008

Isis Reports Financial Results and Highlights for Third Quarter of 2008

11/10/08 View all Trade Related Articles > | The Pink Sheet Daily

Friday, October 3, 2008

Isis Pharmaceuticals, Inc. Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics

10/3/08 View all Trade Related Articles > | PharmaInfo.net - Canada

Tuesday, September 23, 2008

Rosetta Genomics Announces Transfer of MicroRNA-based Liver Therapeutics Project With Isis Pharmaceuticals, Inc. to Regulus Therapeutics LLC (PR Newswire)

9/23/08 View all Trade Related Articles > | PharmCast.com

Wednesday, August 27, 2008

Novosom AG Acquires Exclusive License from Isis Pharmaceuticals, Inc. For CD40-Targeted Antisense Inhibitors

8/27/08 View all Trade Related Articles > | Biocompare

Thursday, August 14, 2008

Isis Pharmaceuticals, Inc. (ISIS) Initiates Clinical Trial of CRP Drug Reduction of CRP with ISIS 353512

8/14/08 View all Trade Related Articles > | Biocompare

Thursday, August 7, 2008

Isis Pharmaceuticals, Inc. Posts Narrower-Than-Expected Q2 Loss

8/7/08 View all Trade Related Articles > | Pharm Country

Thursday, July 31, 2008

Webcast Alert: Isis Pharmaceuticals Announces Second Quarter 2008 Financial Results Conference Call

7/31/08 | PharmaLive

Thursday, July 17, 2008

Isis Announces Appointment of Martin P. Bedigian, M.D. as Vice President and Chief Medical Officer

7/17/08 View all Trade Related Articles > | PharmaLive

Tuesday, July 1, 2008

Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call

7/1/08 View all Trade Related Articles > | The Pink Sheet Daily

Monday, June 30, 2008

Isis Pharmaceuticals Conference Call Notice

6/30/08 View all Trade Related Articles > | PharmaLive

Wednesday, June 25, 2008

Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS) Complete Licensing Of Mipomersen

6/25/08 View all Trade Related Articles > | Biocompare

Friday, May 30, 2008

Isis Pharmaceuticals Announces Extension Of Antisense Cancer Drug Discovery Collaboration With Lilly

5/30/08 | Biocompare

1 <Next>
Thursday, April 10, 2008

Isis Pharmaceuticals VP exercises options for 12,200 shares

4/10/08 | San Diego Daily Transcript - San Diego CA

Friday, April 4, 2008

Isis Pharmaceuticals senior VP exercises options

4/4/08 | San Diego Daily Transcript - San Diego CA

Thursday, March 13, 2008

Isis Pharmaceuticals 4th-quarter loss narrows, helped by higher R&D revenue

3/13/08 View all Regional Related Articles > | CBS - WJZ 13 - Baltimore MD

Monday, October 8, 2007

Isis Pharmaceuticals cuts 2007 loss estimate, seeing gains from acquisition and collaboration

10/8/07 View all Regional Related Articles > | CBS - CBS 11 - Dallas / Fort Worth TX

ISIS Pharmaceuticals to host call on new drug data, analysts reiterate positive views

10/8/07 View all Regional Related Articles > | CBS 4 - Miami FL

Friday, October 5, 2007

Morning Briefing: Isis Pharmaceuticals cites positive safety data for cholesterol drug candidate

10/5/07 | San Diego Daily Transcript - San Diego CA

1
Wednesday, October 28, 2009

Regulus Announces U.S. Allowance of Fundamental microRNA Therapeutics Patent Application

10/28/09 | Business Wire

Tuesday, October 27, 2009

Webcast Alert: Isis Pharmaceuticals' Third Quarter 2009 Financial Results Conference Calls

10/27/09 | PR Newswire

Wednesday, October 21, 2009

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 113715 in Patients With Type 2 Diabetes

10/21/09 | PR Newswire

Tuesday, October 20, 2009

Isis Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference

10/20/09 | PR Newswire

Tuesday, September 29, 2009

Isis Pharmaceuticals to Present at the 4th Annual JMP Securities Healthcare Focus Conference

9/29/09 | PR Newswire

Thursday, September 17, 2009

Regulus, Alnylam, and Isis Announce First microRNA Patent Grant in Japan from Tuschl III Patent Series

9/17/09 | Business Wire

Wednesday, September 16, 2009

Regulus Therapeutics Appoints Hubert C. Chen, M.D., Vice President of Translational Medicine

9/16/09 | Business Wire

Thursday, September 10, 2009

Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology

9/10/09 | PR Newswire

Wednesday, September 9, 2009

Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged Conference

9/9/09 | PR Newswire

Thursday, September 3, 2009

Isis Pharmaceuticals to Present at Thomas Weisel Partners' Healthcare Conference 2009

9/3/09 | PR Newswire

Friday, August 14, 2009

Beacon Equity Issues Trading Outlook for Isis Pharmaceuticals

8/14/09 | GlobeNewswire

Tuesday, August 11, 2009

Alnylam and Regulus Receive Notice of Allowance from United States Patent and Trademark Office for New Patent Covering microRNA Therapeutics

8/11/09 | Business Wire

Thursday, August 6, 2009

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

8/6/09 | PR Newswire

Tuesday, August 4, 2009

Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth Conference

8/4/09 | PR Newswire

Thursday, July 23, 2009

Webcast Alert: Isis Pharmaceuticals' Second Quarter 2009 Financial Results Conference Call

7/23/09 | PR Newswire

Wednesday, June 24, 2009

Zacks Analyst Blog Highlights: Tiffany, Big Lots, Family Dollar, Isis Pharmaceuticals and OncoGenex

6/24/09 | Business Wire

Thursday, June 18, 2009

Antisense Therapeutics Drug ATL1101 Enhances Effect of Existing Chemotherapy Treatment on Prostate Tumors

6/18/09 | Marketwire

Thursday, June 11, 2009

Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference

6/11/09 | PR Newswire

Tuesday, June 9, 2009

Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions

6/9/09 | PR Newswire

Friday, June 5, 2009

Isis Pharmaceuticals to Present at Needham's 8th Annual Life Sciences Conference

6/5/09 | PR Newswire

Thursday, June 4, 2009

Isis Pharmaceuticals to Present at Goldman Sachs' 30th Annual Global Healthcare Conference

6/4/09 | PR Newswire

Monday, June 1, 2009

Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders

6/1/09 | PR Newswire

Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO

6/1/09 | PR Newswire

Wednesday, May 20, 2009

Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint

5/20/09 | Business Wire

Tuesday, May 19, 2009

Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders

5/19/09 | PR Newswire

Thursday, May 14, 2009

Regulus Therapeutics Achieves Initial Milestone in its Inflammatory Diseases Collaboration with GlaxoSmithKline

5/14/09 | Business Wire

Thursday, May 7, 2009

Isis Reports Strong Financial Results and Highlights for First Quarter of 2009

5/7/09 | PR Newswire

Friday, May 1, 2009

Isis and Collaborators Present New Research at the ATVB Annual Conference

5/1/09 | PR Newswire

Wednesday, April 29, 2009

Isis and Alnylam Form New Collaboration to Develop Single-Stranded RNAi Technology

4/29/09 | Business Wire

Thursday, April 23, 2009

Webcast Alert: Isis Pharmaceuticals' First Quarter 2009 Financial Results Conference Call

4/23/09 | GlobeNewswire

Monday, April 20, 2009

Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting

4/20/09 | PR Newswire

Tuesday, April 7, 2009

Zacks Analyst Blog Highlights: Isis Pharmaceuticals, Cosan Ltd., Petrobras, Bristol-Myers Squibb Co. and HSBC Holdings plc

4/7/09

Live Updates:

Ticker

Dynamic view of the market

ISIS PHARMACEUTICALS INC

ISIS

Stock price

Extended Hours

ISIS PHARMACEUTICALS INC Real-Time Headlines

Friday, November 6, 2009

Thursday, November 5, 2009

Thursday, October 29, 2009

Wednesday, October 28, 2009

Tuesday, October 27, 2009

Friday, October 23, 2009

Thursday, October 22, 2009

Wednesday, October 21, 2009

Tuesday, October 20, 2009

Tuesday, October 6, 2009

Friday, October 2, 2009

Thursday, October 1, 2009

Tuesday, September 29, 2009

Thursday, September 17, 2009

Wednesday, September 16, 2009

Tuesday, September 15, 2009

Thursday, September 10, 2009

Wednesday, September 9, 2009

Tuesday, September 8, 2009

Thursday, September 3, 2009

Wednesday, September 2, 2009

Monday, August 17, 2009

Friday, August 14, 2009

Tuesday, August 11, 2009

Thursday, August 6, 2009

Friday, November 6, 2009

Thursday, November 5, 2009

Wednesday, October 28, 2009

Friday, October 23, 2009

Thursday, October 22, 2009

Wednesday, October 21, 2009

Tuesday, October 6, 2009

Friday, October 2, 2009

Thursday, October 1, 2009

Tuesday, September 15, 2009

Tuesday, September 8, 2009

Wednesday, September 2, 2009

Monday, August 17, 2009

Friday, August 14, 2009

Thursday, August 6, 2009

Friday, July 24, 2009

Tuesday, July 21, 2009

Thursday, July 16, 2009

Wednesday, July 8, 2009

Thursday, July 2, 2009

Tuesday, June 30, 2009

Friday, June 26, 2009

Wednesday, June 24, 2009

Tuesday, June 23, 2009

Wednesday, June 17, 2009

Thursday, June 11, 2009

Tuesday, June 9, 2009

Friday, June 5, 2009

Thursday, October 29, 2009

Wednesday, October 28, 2009

Thursday, October 22, 2009

Tuesday, September 29, 2009